Background Despite being one of the commonest causes of cancer-related death around
the world, only 20 per cent of hepatocellular carcinomas (HCCs) are amenable to curative …

Background: The effectiveness of tumor markers in evaluating outcomes of patients with
hepatocellular carcinoma (HCC) remains to be clarified. Summary: The usefulness of the …

Background Hepatocellular carcinoma (HCC) is one of the most common malignant tumors
of the digestive system and has high morbidity and mortality rates. It is essential to search …

Abstract Background: Updated National Academy of Clinical Biochemistry Laboratory
Medicine Practice Guidelines for the use of tumor markers in the clinic have been …

Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in some
areas of the world. In most cases, HCC is diagnosed at a late stage. Therefore, the …

Objectives To evaluate the efficacy and safety of radiofrequency ablation (RFA) versus
hepatic resection (HR) for early hepatocellular carcinoma (HCC) meeting the Milan criteria …

Hepatocellular carcinoma (HCC) is one of the most frequently occurring malignancies and
has a high mortality rate. The incidence of HCC differs greatly according to the geographic …

Des-gamma-carboxy prothrombin (DCP) levels reportedly correlate with histological
features of hepatocellular carcinoma (HCC). We examined serum DCP as a predictor of …

Background Alpha-fetoprotein (AFP) and prothrombin induced by vitamin K absence-II
(PIVKA-II) are two commonly used biomarkers for detection and prognostic prediction of …

Abstract Des‐γ‐carboxyprothrombin (DCP) is known as a tumour marker for hepatocellular
carcinoma (HCC). Various tumour markers have been developed for serological diagnosis …